Cummings Keith Lamont

Chief Financial OfficerPLIANT THERAPEUTICS, INC. (PLRX) · full profile →Form 4 · filed Apr 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
14
0 non-derivative · 14 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 17, 2026Disposed to issuer(D)76K$00
Apr 17, 2026Grant(A)76K$076K
Apr 17, 2026Disposed to issuer(D)18K$00
Apr 17, 2026Grant(A)18K$018K
Apr 17, 2026Disposed to issuer(D)74K$00
Apr 17, 2026Grant(A)74K$074K
Apr 17, 2026Disposed to issuer(D)124K$00
Apr 17, 2026Grant(A)124K$0124K
Apr 17, 2026Disposed to issuer(D)76K$00
Apr 17, 2026Grant(A)76K$076K
Apr 17, 2026Disposed to issuer(D)111K$00
Apr 17, 2026Grant(A)111K$0111K
Apr 17, 2026Disposed to issuer(D)113K$00
Apr 17, 2026Grant(A)113K$0113K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001746473-26-000054) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.